| Ytd | 0.86% | |
| 1y | -6.12% |
| Open | 1.76 | Prev Close | 1.76 | Low | 1.75 | High | 1.78 | Mkt Cap | 165.74M |
| Vol | 480.00 | Avg Vol | 67.37K | EPS | -0.64 | P/E | -2.78 | Forward P/E | 4.67 |
| Beta | 0.87 | Short Ratio | 5.63 | Inst. Own | 0.50% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-13 | 50-d Avg | 1.80 | 200-d Avg | 1.74 | 1yr Est | 7.41 |
IPHA News
Enrollment completed in the dose escalation of IPH4502-101 study, with preliminary data readout from
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced th
MARSEILLE, France--(BUSINESS WIRE)--Outcome of Innate Pharma's 2026 Annual General Meeting.
/PRNewswire/ -- USA News Group News Commentary - For more than two decades, B7-H3 sat on the shortli
Innate Pharma NASDAQ: IPHA said its first-quarter 2026 business update centered on three priority cl
MARSEILLE, France--(BUSINESS WIRE)---- $IPH #ADC--Regulatory News: Innate Pharma SA (Euronext Paris:
MARSEILLE, France--(BUSINESS WIRE)--Number of shares and voting rights of Innate Pharma as of April
MARSEILLE, France--(BUSINESS WIRE)---- $Innate #Biotech--Innate Pharma announces conference call and
MARSEILLE, France--(BUSINESS WIRE)-- #Biotech--Innate Pharma to participate in the D. Boral Capital
MARSEILLE, France--(BUSINESS WIRE)-- #immunotherapy--Regulatory News: Innate Pharma SA (Euronext Par
MARSEILLE, France--(BUSINESS WIRE)--Number of shares and voting rights of Innate Pharma as of April
MARSEILLE, France--(BUSINESS WIRE)-- #Actionnaires--Innate Pharma to hold its annual general meeting
MARSEILLE, France--(BUSINESS WIRE)-- #AACR--Regulatory News: Innate Pharma SA (Euronext Paris: IPH;
MARSEILLE, France--(BUSINESS WIRE)-- #Biotech--Innate Pharma to participate in the Kempen Life Scien
MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma Files Its 2025 Universal Registration Document (Do
Innate Pharma (NASDAQ: IPHA) outlined progress across its prioritized oncology pipeline and reviewed
Innate Pharma S.A. (IPHA) Q4 2025 Earnings Call Transcript
MARSEILLE, France--(BUSINESS WIRE)-- #immunotherapy--Regulatory News: Innate Pharma SA (Euronext Par
MARSEILLE, France--(BUSINESS WIRE)-- #Biotech--Innate Pharma announces conference call and webcast f
MARSEILLE, France--(BUSINESS WIRE)--Number of shares and voting rights of Innate Pharma as of Februa
MARSEILLE, France--(BUSINESS WIRE)-- #Biotech--Innate pharma to participate in the Leerink Partners
During Monday's session, 402 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday